The Akershus Study of Ischemic Stroke and Thrombolysis -1

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

A vizsgálat olyan felnőtteket keres, akiket az akershusi egyetemi kórház (Norvégia) stroke-osztályára vettek fel agyi érbetegség, agyvérzés, átmeneti agyi keringészavar (TIA) vagy stroke-ra hasonlító állapot miatt.

Életkor

18 év vagy idősebb

Nem

Mindkét nem részt vehet

A betegség stádiuma

Agyi érbetegség: heveny ischaemiás stroke, agyállományi vérzés, átmeneti agyi keringészavar (TIA) vagy stroke-ra hasonlító állapot

A regiszter feltételei, szó szerint

Mit akar kideríteni a vizsgálat

This observational study comprises consecutively patients with cerebrovascular diseases admitted to the Stroke Unit at Akershus University Hospital in Norway. Akershus University Hospital is the largest emergency care hospital in Norway and has a catchment area covering a population of 550.000, which is approximately 10 % of the Norwegian population and reasonably representative according to data from Statistics Norway. The hospital is public and serving both as a primary hospital and a university hospital. Due to the Norwegian, national, all-covering health-insurance, all patients enter the hospital and are considered for further in-patient care on the same conditions. The hospital has a stroke unit classified as a comprehensive stroke center according to European Stroke Organisation standards. Acute stroke management follows national and international guidelines. Overall, the ASIST-1 study will investigate management, outcome and prognosis of stroke and stroke care pathways and later follow up in primary care using several approaches combining existing clinical data from a representative population with different Norwegian health registries. Parts of the study are retrospective with prospective follow-up by health registries and parts of the study are prospective.

A vizsgálat 6 csoportja

• Intravenous thrombolysis (IVT)

  All patients treated with IVT in the acute stroke care pathway 2012-2025

• Intracerebral hemorrhage (ICH)

  All patients with intracerebral hemorrhage 2012-2019

• Acute ischemic stroke (AIS) and Intracerebral hemorrhage (ICH)

  All patients with acute ischemic stroke or intracerebral hemorrhage 2015-2017

• Stoke care pathway

  All patients admitted to the stroke care pathway (ischemic stroke, intracerebral hemorrhage, transient ischemic attack and stroke mimics) 2015-2017

• Endovascular treatment

  All stroke patients treated with endovascular treatment 2012-2025

• Cerebellar hematoma (cICH)

  All patients with cerebellar hematoma 2008-2019